Unicept Pharma Private Limited
About Unicept Pharma Private Limited
Data last updated:
Unicept Pharma Private Limited is a private limited company based in Karmanghat, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 September 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2013PTC089820. Its GSTIN is 36AABCU6235D1ZJ (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jyotsna Polepally and Vinaya Kathagandla.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Karmanghat, Telangana.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Unicept Pharma has one previous CIN (Corporate Identification Number): U24232AP2013PTC089820. The current CIN is U24232TG2013PTC089820, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2013PTC089820 | Current |
| U24232AP2013PTC089820 | Previous |
Contact details
Unicept Pharma Private Limited's registered office is in Karmanghat, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No.39 Door No.10 – 1 – 74/8/1/ 5th Floor Yashoda Pride Near Bajaj Electronics Li, Ngojiguda, Karmanghat, Telangana, India – 500079
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Unicept Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Unicept Pharma Private Limited
FY 2023 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Unicept Pharma Private Limited, buy the company report.
Board of directors of Unicept Pharma Private Limited
Unicept Pharma has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jyotsna Polepally | Director | 18 Apr 2018 | 8 Years 6 Months | Current |
| Vinaya Kathagandla | Director | 18 Apr 2018 | 8 Years 6 Months | Current |
Auditor
Unicept Pharma Private Limited is audited by SHEKAR & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHEKAR & CO | FY 2020 | 014594S |
Shareholding
The shareholding of Unicept Pharma Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Unicept Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Unicept Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Unicept Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Unicept Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCU6235D1ZJ | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Unicept Pharma Private Limited, buy the company report.
Recent activity
Unicept Pharma Private Limited has 10 board changes on record since 2018: 2 appointments and 8 cessations. The latest: Balachandar Aluri ceased to be Additional Director on 27 Sep 2018.
1 earlier event is in the company report.
Frequently asked questions
Unicept Pharma is an active private limited company based in Karmanghat, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 September 2013 (13+ years old) and is registered under CIN U24232TG2013PTC089820.
Unicept Pharma has 2 current directors:
- Jyotsna Polepally - Director
- Vinaya Kathagandla - Director
The latest financial statements of Unicept Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Unicept Pharma is 36AABCU6235D1ZJ, registered in Telangana.
The CIN (Corporate Identification Number) of Unicept Pharma is U24232TG2013PTC089820. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unicept Pharma was incorporated on 02 September 2013, making it 13+ years old. It is registered with the Registrar of Companies, Hyderabad.
Balachandar Aluri ceased to be Additional Director on 27 Sep 2018. Jyotsna Polepally ceased to be Additional Director on 27 Sep 2018. Kethavat Ashok Kumar ceased to be Additional Director on 27 Sep 2018. Unicept Pharma has 10 board changes on record in total.
The registered office of Unicept Pharma is at Plot No.39 Door No.10 – 1 – 7481 5th Floor Yashoda Pride Near Bajaj Electronics Li, Ngojiguda, Karmanghat, Telangana, India – 500079.
Unicept Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Unicept Pharma is compliant as of 31 July 2026. The company is actively filing with the Registrar of Companies.